Publications by authors named "Ralph Mosges"

Claim this Profile
T
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based Approach.
Oliver Pfaar, Ralph Mösges, Michael S Blaiss, Sven Becker, Lawrence DuBuske

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.
Sandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar, Esther Raskopf, Anna Rybachuk

J Clin Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial.
Thorsten Lehr, Peter Meiser, Dominik Selzer, Torben Rixecker, Frank Holzer

JAMA Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen Immunotherapy with Depigmented-Polymerised Cat Allergoid Is Safe and Well-Tolerated in Patients with Allergic Rhinitis/Rhinoconjunctivitis.
Ralph Mösges, Anna Rybachuk, Edmund Curtius, Cengizhan Acikel, Anne Drevermann

J Clin Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites.
Désirée Larenas-Linnemann, Ralph Mosges

Allergy Asthma Proc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial.
Stefan Zielen, Jonathan A Bernstein, Gunter J Sturm, Marek Jutel, Oliver Pfaar

Allergy· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis of PQ Grass 27600 SU Efficacy and Quality of Life From Phase III Trials.
Stefan Zielen, Jonathan A Bernstein, Oliver Pfaar, Lawrence DuBuske, Ralph Mösges

Allergy· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On a Rainy Day, Placebo Is the Ideal Treatment for Your Hay Fever.
Ralph Mösges

Allergy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Algorithms in Allergy: Organ-Specific Allergen Challenges for the Phenotyping of Chronic Respiratory Diseases.
Dulce Sanchez-Torralvo, Almudena Testera-Montes, Guillermo Bentabol-Ramos, Ibon Eguiluz-Gracia, Ralph Mösges

Allergy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy.
Ralph Mösges, Esther Raskopf, Ludger Klimek, Oliver Pfaar, Stefan Zielen

Allergy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study.
Bernardo Sousa-Pinto, Elísio M Costa, Rafael José Vieira, Ludger Klimek, Wienczyslawa Czarlewski

Clin Exp Allergy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported therapeutic benefits of herbal medicinal products in the treatment of gynecological ailments.
Alexandra Drebka, Annika J Scholl, Teresa Ochs, Olaf Kelber, Ralph Mösges

BMC Complement Med Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysensitisation is associated with more severe symptoms: The reality of patients with allergy.
Cristina Cacheiro-Llaguno, Ralph Mösges, David Calzada, Sandra González-de la Fuente, Eliana Quintero

Clin Exp Allergy· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper.
Oliver Pfaar, Bernardo Sousa-Pinto, Nikolaos G Papadopoulos, Désirée E Larenas-Linnemann, Michal Ordak

Allergy· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays.
Virginia Patterlini, Fabiola Guareschi, Davide D'Angelo, Simone Baldini, Suada Meto

Pharmaceutics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study.
Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, Ralph Mösges, Zoltan Novak

Drugs Context· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial with mannan-conjugated birch pollen allergoids.
Ralph Mösges, Christoph Zeyen, Esther Raskopf, Cengizhan Acikel, Hacer Sahin

Allergy· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio.
Oliver Pfaar, Angelika Sager, Ralph Mösges, Margitta Worm

Clin Transl Allergy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Tolerability of Ectoin Mouth and Throat Spray Althaea Honey (ERS09) for Sore Throat due to Acute Pharyngitis and Dry Cough: A Multicentre, Actively Controlled, Open Label Study in Germany.
Don Lorenzo Constantin Roventa, Ursula Pieper-Fürst, Cengizhan Acikel, Dunia Santos, Ulrike Sent

J Clin Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study.
Jean Bousquet, Bernardo Sousa-Pinto, Mohamed H Shamji, Josep M Anto, Ludger Klimek

Clin Exp Allergy· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of AI-based software for objectification of conjunctival provocation test.
Yury Yarin, Alexandra Kalaitzidou, Kira Bodrova, Ralph Mösges, Yannis Kalaidzidis

J Allergy Clin Immunol Glob· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhinosinusitis Treatment with Cineole: Patient-Reported Quality of Life Improvements from a Non-Interventional, Pharmacy-Based Survey.
Nina Werkhäuser, Ursula Pieper-Fürst, Hacer Sahin, Antonia Claas, Ralph Mösges

Medicines (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis.
Philippe Gevaert, Jarno De Craemer, Claus Bachert, Manon Blauwblomme, Adam Chaker

Allergy· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.
Jens Peter Klussmann, Maria Grosheva, Peter Meiser, Clara Lehmann, Eszter Nagy

Sci Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air approach.
Jean Bousquet, Josep M Anto, Bernardo Sousa-Pinto, Wienczyslawa Czarlewski, Anna Bedbrook

Clin Transl Allergy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis